Journal Article
. 2011 Sep; 9(8):914-32.
doi: 10.6004/jnccn.2011.0075.

Myeloid growth factors

Jeffrey Crawford 1 Jeffrey Allen  James Armitage  Douglas W Blayney  Spero R Cataland  Mark L Heaney  Sally Htoy  Susan Hudock  Dwight D Kloth  David J Kuter  Gary H Lyman  Brandon McMahon  David P Steensma  Saroj Vadhan-Raj  Peter Westervelt  Michael Westmoreland  National Comprehensive Cancer Network  
  • PMID: 21900221
  •     17 citations

No abstract available

A way forward on the medically appropriate use of white cell growth factors.
Thomas J Smith, Bruce E Hillner.
J Clin Oncol, 2012 Mar 01; 30(14). PMID: 22370327    Free PMC article.
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
Bradford R Hirsch, Gary H Lyman.
Pharmacoeconomics, 2012 May 01; 30(6). PMID: 22540394
Systematic Review.
Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer.
Edgar Petru, Alain Gustave Zeimet, +9 authors, Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO).
Wien Klin Wochenschr, 2012 Jun 29; 124(11-12). PMID: 22739650
Supportive therapy in medical therapy of head and neck tumors.
Hartmut Link.
GMS Curr Top Otorhinolaryngol Head Neck Surg, 2013 Jan 16; 11. PMID: 23320053    Free PMC article.
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
S Neumann, S W Krause, +4 authors, German Society of Hematology and Oncology (DGHO).
Ann Hematol, 2013 Feb 16; 92(4). PMID: 23412562    Free PMC article.
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials.
G H Lyman, D C Dale, +5 authors, J Crawford.
Ann Oncol, 2013 Jun 22; 24(10). PMID: 23788754    Free PMC article.
Systematic Review.
Comparison of pegfilgrastim prescribing practice to national guidelines at a university hospital outpatient oncology clinic.
Geralyn E Waters, Patricia Corrigan, Mandy Gatesman, Thomas J Smith.
J Oncol Pract, 2013 Aug 15; 9(4). PMID: 23942922    Free PMC article.
Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practice.
K Krzemieniecki, P Sevelda, +7 authors, J Maenpaa.
Support Care Cancer, 2013 Oct 25; 22(3). PMID: 24154740    Free PMC article.
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.
Eva Culakova, Ramya Thota, +5 authors, Gary H Lyman.
Cancer Med, 2014 Apr 08; 3(2). PMID: 24706592    Free PMC article.
Myeloid toxicity of cancer treatment.
Sandra Kurtin.
J Adv Pract Oncol, 2012 Jul 01; 3(4). PMID: 25031949    Free PMC article.
Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer.
Keisuke Shigeta, Takeo Kosaka, +10 authors, Mototsugu Oya.
Int J Clin Oncol, 2014 Sep 10; 20(3). PMID: 25196861
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.
Alena M Pfeil, Kim Allcott, +3 authors, Zsolt Szabo.
Support Care Cancer, 2014 Oct 07; 23(2). PMID: 25284721
Systematic Review.
Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy.
Yasunori Hashiguchi, Mari Kasai, +3 authors, Toshiyuki Sumi.
Anticancer Drugs, 2015 Aug 13; 26(10). PMID: 26267078    Free PMC article.
Harnessing the immune system in the battle against breast cancer.
Elizabeth S Nakasone, Sara A Hurvitz, Kelly E McCann.
Drugs Context, 2018 Feb 20; 7. PMID: 29456568    Free PMC article.
An internet-based survey exploring the awareness of febrile neutropenia in patients with malignant lymphoma.
Yasushi Takamatsu, Isao Yoshida, Minoru Yoshida.
Support Care Cancer, 2020 Jan 19; 28(9). PMID: 31953622    Free PMC article.
Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study.
Jean Paul Salmon, Martin Smakal, +5 authors, James O'Kelly.
Support Care Cancer, 2018 Sep 28; 27(4). PMID: 30259136
Infectious complications during immunochemotherapy of post-transplantation lymphoproliferative disease-can we decrease the risk? Two case reports and review of literature.
Aleksandra Gładyś, Sylwia Kozak, +2 authors, Jerzy Chudek.
World J Clin Cases, 2021 Feb 09; 9(3). PMID: 33553416    Free PMC article.